Connect with us

Australia

Australian Potash gets 23 cents target price and Speculative Buy rating from Patersons

Australian Potash Ltd (ASX:APC) is primarily focused on developing its 100%-owned Lake Wells Sulphate of Potash Project (LWSOP) in WA.

In August 2019, the company released its Definitive Feasibility Study (DFS) on Lake Wells, with results showing a robust and low-cost Sulphate of Potash (SOP) project that has the potential to supply up to 150,000 tonnes per annum of SOP to overseas and domestic markets.

Patersons Securities has initiated coverage of APC with a Speculative Buy rating and a 23 cents per share valuation.

Following is an extract from Patersons research note on APC.

Investment Highlights
A low-cost long-life project. The LWSOP project, located in one of the worlds superior locations for solar evaporation operations offers a compelling low-cost long-life development opportunity as the demand for premium grade fertilizer products like SOP continue to rise in Asia and the rest of the world. With total measured drainable SOP resource of 18.1Mt, evaporated through sun and wi..

Australian Potash Ltd (ASX:APC) is primarily focused on developing its 100%-owned Lake Wells Sulphate of Potash Project (LWSOP) in WA.

In August 2019, the company released its Definitive Feasibility Study (DFS) on Lake Wells, with results showing a robust and low-cost Sulphate of Potash (SOP) project that has the potential to supply up to 150,000 tonnes per annum of SOP to overseas and domestic markets.

Patersons Securities has initiated coverage of APC with a Speculative Buy rating and a 23 cents per share valuation.

Following is an extract from Patersons research note on APC.

Investment Highlights

A low-cost long-life project. The LWSOP project, located in one of the worlds superior locations for solar evaporation operations offers a compelling low-cost long-life development opportunity as the demand for premium grade fertilizer products like SOP continue to rise in Asia and the rest of the world. With total measured drainable SOP resource of 18.1Mt, evaporated through sun and wind, APC will look to supply overseas and domestic markets with up to 150ktpa of SOP for at least the next 30 years. DFS results indicate life of mine (LOM) operating costs of US$262/t, placing the LWSOP project in the first quartile of the SOP cost curve.

Robust Financial Returns. DFS results indicate the project boasts a pretax NPV8 of A$665M with an internal rate of return (IRR) of 25% on robust operational and capital efficiencies. These economics are based on the Projects Probable Reserves of 3.6Mt SOP, which account for 95% of the LOM output, with the remaining 5% coming from the Measured Resource (18.1Mt). Overall, the project has a 30-year mine life with LOM production of 4.5Mt of premium high-grade SOP.

SOP price outlook looks stable. Historically, SOP prices have not been subject to the saRead More – Source

Continue Reading

Australia

S&P/ASX 200 rallies 2.16% for its best daily performance this month

S&P/ASX 200 (INDEXASX:XJO) has started the week on a firm note advancing 118 points or 2.16% to 5,615.

The index outperformed the Asian markets which were mixed while US and UK markets are closed due to public holidays.

Several sectors have gained more than 2% with healthcare, consumer discretionary, energy, industrials and IT among them.

As lockdown restrictions are slowly being lifted in different states, travel retailer stocks have surged with Flight Centre (ASX:FLT) up 15% and Webjet (ASX:WEB) gaining 16%.

The miners managed healthy gains with BHP Group Ltd (ASX:BHP) rising 1.28% and Rio Tinto Limited (ASX:RIO) up 1.29%. Fortescue Metals Group Limited (ASX:FMG) rose 1.91%.

There were multiple stocks rising more than 10% including Great Southern Mining Ltd (ASX:GSN) (+14.29%), Polarx Ltd (ASX:PXX) (+27.59%), Moho Resources Lt, (ASX:MOH) (+10.29%), Nanoveu Ltd, (ASX:NVU) (+29.41%), Kin Mining NL (ASX:KIN) (+11.54%), Volt Resources Ltd (ASX:VRC) (+33.33%), Strategic Elements Ltd ..

S&P/ASX 200 (INDEXASX:XJO) has started the week on a firm note advancing 118 points or 2.16% to 5,615.

The index outperformed the Asian markets which were mixed while US and UK markets are closed due to public holidays.

Several sectors have gained more than 2% with healthcare, consumer discretionary, energy, industrials and IT among them.

As lockdown restrictions are slowly being lifted in different states, travel retailer stocks have surged with Flight Centre (ASX:FLT) up 15% and Webjet (ASX:WEB) gaining 16%.

The miners managed healthy gains with BHP Group Ltd (ASX:BHP) rising 1.28% and Rio Tinto Limited (ASX:RIO) up 1.29%. Fortescue Metals Group Limited (ASX:FMG) rose 1.91%.

There were multiple stocks rising more than 10% including Great Southern Mining Ltd (ASX:GSN) (+14.29%), Polarx Ltd (ASX:PXX) (+27.59%), Moho Resources Lt, (ASX:MOH) (+10.29%), Nanoveu Ltd, (ASX:NVU) (+29.41%), Kin Mining NL (ASX:KIN) (+11.54%), Volt Resources Ltd (ASX:VRC) (+33.33%), Strategic Elements Ltd (ASX:SOR) (11.11%), PNX Metals Ltd (ASX:PNX) (+14.29%), St George Mining Ltd (ASX:SGQ) (+12.36%), Castillo Copper Ltd (ASX:CCZ) (+26.32%), Chase Mining Corporation Ltd (ASX:CML) (13.33%), Aeris Resources Ltd (ASX:AIS) (+16.28%), Argosy Minerals Limited (ASX:AGY) (+12.28%), Alice Queen Ltd (ASX:AQX) (+16.67%), Archer Materials Ltd (ASX:AXE) (+29.91%), Broken Hill Prospecting Ltd (ASX:BPL) (+27.78%), European Lithium Ltd (ASX:EUR) (+13.79%) Australian Mines Limited (ASX:AUZ) (+11.11%).

Proactive news headlines:

Archer Materials a market mover with shares up as much as 35% to record high


Archer Materials Ltd (ASX:AXE) is a strong ASX market mover today with shares up as much as 35% on the previous close to a new record high of 78 cents. The previous all-time high was 45 cents on May 1, 2012. Archer has been performing well this month on the back of strong newsflow with shares up from 18 cents on May 1 and a market cap of approximately $114.1 million.

Nanoveu shares surge as antiviral technology independently validated against human coronaviruses


Nanoveu Ltd (ASX:NVU) has more than doubled on receiving further successful independent testing of its antiviral technology against the human transmitted coronavirus strain OC43 by Bioscience Laboratories, at its testing facility in Montana, USA. Testing involved placing a solution containing OC43 strain coronaviruses on a thin film containing the antiviral technology. The company's antiviral protectors protect smartphone and tablet users from viruses and bacteria.

TNT Mines to acquire high-grade US uranium project as the metal price rallies 36% year to date


TNT Mines Ltd (ASX:TIN) has entered into a binding agreement to acquire Vanacorp Aust Pty Ltd which owns the East Canyon Uranium-Vanadium Project in Utah, US. The project comprises 200 unpatented lode claims prospective for uranium and vanadium in the Dry Valley/East Canyon mRead More – Source

Continue Reading

Australia

Archer Materials a market mover with shares up as much as 35% to record high

Archer Materials Ltd (ASX:AXE) is a strong ASX market mover today with shares up as much as 35% on the previous close to a new record high of 78 cents.

The previous all-time high was 45 cents on May 1, 2012.

Archer has been performing well this month on the back of strong newsflow with shares up from 18 cents on May 1 and a market cap of approximately $114.1 million.

Strong volumes[hhmc]
Trading volumes have also been high with more than 92 million shares traded so far this month compared to a daily average below 1 million for the previous three months.

The announcement on May 5 of an agreement with International Business Machines Corporation (NYSE:IBM) to work together on advancing quantum computing saw more than 20 million shares traded on that day and shares more than doubling to a new 8-year high of 38 cents.

Collaborating with IBM[hhmc]
As part of this agreement, Archer is now a member of the IBM Q Network and associated IBM Quantum Experience for Business program.

Archer is..

Archer Materials Ltd (ASX:AXE) is a strong ASX market mover today with shares up as much as 35% on the previous close to a new record high of 78 cents.

The previous all-time high was 45 cents on May 1, 2012.

Archer has been performing well this month on the back of strong newsflow with shares up from 18 cents on May 1 and a market cap of approximately $114.1 million.

Strong volumes


Trading volumes have also been high with more than 92 million shares traded so far this month compared to a daily average below 1 million for the previous three months.

The announcement on May 5 of an agreement with International Business Machines Corporation (NYSE:IBM) to work together on advancing quantum computing saw more than 20 million shares traded on that day and shares more than doubling to a new 8-year high of 38 cents.

Collaborating with IBM


As part of this agreement, Archer is now a member of the IBM Q Network and associated IBM Quantum Experience for Business program.

Archer is the first Australian company developing a quantum computing processor and hardware to join the invitation-only, IBM Q Network.

Archer CEO Dr Mohammad Choucair said: “We are the first Australian company building a quantum chip to join into the global IBM Q Network as an ecosystem partner, a group of the very best organisations at the forefront of quantum computing.

“Ultimately, we want Australian businesses and consumers to be one of the first beneficiaries of this exciting technology, and now that we are collaborating with IBM, it greatly increases our chances of success.

“We look forward to working with IBM and members of the network to address the most fundamental challenges to the wide-scale adoption of quantum computing, using our potentially complementary technologies as starting points.”

Patent application proceeds


Also, this month shares rose on news that a licensed European Patent (EP) application filed under the Patent Cooperation Treaty for AXEs 12CQ quantum computing chip materials technologyRead More – Source

Continue Reading

Australia

Nanoveu shares surge as antiviral technology independently validated against human coronaviruses

Nanoveu Ltd (ASX:NVU) has more than doubled on receiving further successful independent testing of its antiviral technology against the human transmitted coronavirus strain OC43 by Bioscience Laboratories, at its testing facility in Montana, USA.

Testing involved placing a solution containing OC43 strain coronaviruses on a thin film containing the antiviral technology.

The company's antiviral protectors protect smartphone and tablet users from viruses and bacteria.

Betacoronavirus targeted[hhmc]
In line with Nanoveus testing of the MHV-A59 strain, which demonstrated 90% elimination of the virus in just 10 minutes, this recent research on the OC43 strain has targeted a betacoronavirus, which are single-stranded RNA viruses emerging from animals and are typically associated with respiratory ailments.

SARS, MERS, and COVID-19 are all forms of betacoronavirus.

Shares have been as much as 106% higher to 17.5 cents intra-day and are well up from 2.5 cents at close on April 2.

“Str..

Nanoveu Ltd (ASX:NVU) has more than doubled on receiving further successful independent testing of its antiviral technology against the human transmitted coronavirus strain OC43 by Bioscience Laboratories, at its testing facility in Montana, USA.

Testing involved placing a solution containing OC43 strain coronaviruses on a thin film containing the antiviral technology.

The company's antiviral protectors protect smartphone and tablet users from viruses and bacteria.

Betacoronavirus targeted


In line with Nanoveus testing of the MHV-A59 strain, which demonstrated 90% elimination of the virus in just 10 minutes, this recent research on the OC43 strain has targeted a betacoronavirus, which are single-stranded RNA viruses emerging from animals and are typically associated with respiratory ailments.

SARS, MERS, and COVID-19 are all forms of betacoronavirus.

Shares have been as much as 106% higher to 17.5 cents intra-day and are well up from 2.5 cents at close on April 2.

“Strong validation”


Nanoveu executive chairman and CEO Alfred Chong said: “Nanoveu has again received a strong validation from further independent testing of its antiviral technology, which has all but eradicated the coronavirus in half an hour.

“It is particularly pleasing to see that the antiviral technology is not only proven as an effective agent at killing certain strands of coronaviruses but is highly successful at killing viruses capable of infecting humans.

“Given the strong public health focus on COVID-19, these test results represent fantastic news for Nanoveu as well as to the broader population and I am proud to say we are another step closer to providing safer devices for all digital screen users.”

TGA submission


With the completion of the Bioscience Labs testing, Nanoveu now possesses multiple independent research results demonstrating the effectiveness of its antiviral technology against pathogenic betacoronaviruses affecting animals, as well as humans.

These test results wiRead More – Source

Continue Reading

Trending